Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Katial

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Managed Care & Specialty Pharmacy|October 5, 2023
A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspectiveXiao Xu, Caroline Schaefer, Agota Szende, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
THE AUTHORS RESPONDXiao Xu, Rohit Katial, Caroline Schaefer, et al.
American Journal of Respiratory and Critical Care Medicine|January 24, 2018
Rigor Is Needed When Making Comparative Analyses of Biologics in Severe AsthmaCharlene M Prazma, Rohit Katial, Peter Howarth, et al.
BMC Gastroenterology|August 3, 2024
Patient-reported symptoms and burden of eosinophilic esophagitis: evidence from real-world clinical practiceXiao Xu, Justin Kwiatek, James Siddall, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2004
The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthmaPhilip E Silkoff, Mats Carlson, Trevor Bourke, et al.
Allergy, Asthma & Immunology Research|January 2, 2015
Delayed Anaphylaxis to Red Meat Associated With Specific IgE Antibodies to GalactoseLiping Wen, Junxiong Zhou, Jia Yin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 13, 2019
Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 TrialsJ Christian Virchow, Rohit Katial, Guy G Brusselle, et al.
Rheumatology and Therapy|October 24, 2024
Disease Overlap, Healthcare Resource Utilization, and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A REVEAL Sub-studyXiao Xu, Christopher Edmonds, YongJin Kim, et al.
Therapeutic Advances in Gastroenterology|December 10, 2025
Characteristics, treatment patterns, healthcare resource utilization, and costs in patients with eosinophilic esophagitis in the United States: a retrospective analysis of insurance claims dataXiao Xu, Ekaterina Maslova, Danuta Kielar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 25, 2024
Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab ResponsivenessXingnan Li, Paul Newbold, Rohit Katial, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Managed Care & Specialty Pharmacy|October 5, 2023
A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspectiveXiao Xu, Caroline Schaefer, Agota Szende, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
THE AUTHORS RESPONDXiao Xu, Rohit Katial, Caroline Schaefer, et al.
American Journal of Respiratory and Critical Care Medicine|January 24, 2018
Rigor Is Needed When Making Comparative Analyses of Biologics in Severe AsthmaCharlene M Prazma, Rohit Katial, Peter Howarth, et al.
BMC Gastroenterology|August 3, 2024
Patient-reported symptoms and burden of eosinophilic esophagitis: evidence from real-world clinical practiceXiao Xu, Justin Kwiatek, James Siddall, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2004
The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthmaPhilip E Silkoff, Mats Carlson, Trevor Bourke, et al.
Allergy, Asthma & Immunology Research|January 2, 2015
Delayed Anaphylaxis to Red Meat Associated With Specific IgE Antibodies to GalactoseLiping Wen, Junxiong Zhou, Jia Yin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 13, 2019
Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 TrialsJ Christian Virchow, Rohit Katial, Guy G Brusselle, et al.
Rheumatology and Therapy|October 24, 2024
Disease Overlap, Healthcare Resource Utilization, and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A REVEAL Sub-studyXiao Xu, Christopher Edmonds, YongJin Kim, et al.
Therapeutic Advances in Gastroenterology|December 10, 2025
Characteristics, treatment patterns, healthcare resource utilization, and costs in patients with eosinophilic esophagitis in the United States: a retrospective analysis of insurance claims dataXiao Xu, Ekaterina Maslova, Danuta Kielar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 25, 2024
Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab ResponsivenessXingnan Li, Paul Newbold, Rohit Katial, et al.
Pageof 7